Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma

Carcinogenesis

Volumn 31, Issue 10, 2010, Pages 1805-1812

  Lin, Jie ^a   Horikawa, Yohei ^a   Tamboli, Pheroze ^a   Clague, Jessica ^a   Wood, Christopher G ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; DROSHA PROTEIN, HUMAN; GEMIN4 PROTEIN, HUMAN; RIBONUCLEASE III; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ADULT; ALLELE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; AGED; GENETICS; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; GENETIC VARIATION; HAPLOTYPES; HUMANS; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RIBONUCLEASE III; RIBONUCLEOPROTEINS, SMALL NUCLEAR;

EID: 77957785159     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq168     Document Type: Article

References (47)

1. Jemal,A. et al. (2009) Cancer statistics, 2009. CA Cancer J Clin., 59, 225-249.
2. Janzen,N.K. et al. (2003) Laparoscopic radical nephrectomy and minimally invasive surgery for kidney cancer. Cancer Treat. Res., 116, 99-117.
3. Lam,J.S. et al. (2008) Prognostic factors and selection for clinical studies of patients with kidney cancer. Crit. Rev. Oncol. Hematol., 65, 235-262.
4. American Cancer Society. http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_How_is_kidney_cancer_staged_22.asp?rnav5cri (11 August 2009, date last accessed).
5. Escudier, B. (2007) Advanced renal cell carcinoma: current and emerging management strategies. Drugs, 67, 1257-1264.
6. Janzen,N.K. et al. (2003) Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol. Clin. North Am., 30, 843-852.
7. Lee,R.C. et al. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-854.
8. Bentwich,I. et al. (2005) Identification of hundreds of conserved and non-conserved human microRNAs. Nat. Genet., 37, 766-770.
9. Lu,J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
10. Lim,L.P. et al. (2005) Microarray analysis shows that some microRNAs down-regulate large numbers of target mRNAs. Nature, 433, 769-773.
11. Esquela-Kerscher,A. et al. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
12. Han,J. et al. (2006) Molecular basis for the recognition of primary micro-RNAs by the Drosha-DGCR8 complex. Cell, 125, 887-901.
13. Yue,J. et al. (2006) MicroRNA trafficking and human cancer. Cancer Biol. Ther., 5, 573-578.
14. Chendrimada,T.P. et al. (2005) TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature, 436, 740-744.
15. Meng,F. et al. (2006) Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology, 130, 2113-2129.
16. Yanaihara,N. et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-198.
17. Calin,G.A. et al. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl Acad. Sci. USA, 101, 11755-11760.
18. Gu,J. et al. (2005) The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence. Pharmacogenomics, 6, 575-584.
19. Wu,X. et al. (2008) Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Pharmacogenet. Genomics, 8, 955-965.
20. Lin,J. et al. (2008) Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma. Carcinogenesis, 29, 2112-2119.
21. Horikawa,Y. et al. (2008) Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin. Cancer Res., 14, 7956-7962.
22. Yang,H. et al. (2008) Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res., 68, 2530-2536.
23. Benjamini,Y. et al. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. A, B57, 289-300.
24. Zhang,H.P. et al. (1999) Recursive Partitioning in the Health Sciences. Springer, New York, NY.
25. Shpargel,K.B. et al. (2005) Gemin proteins are required for efficient assembly of Sm-class ribonucleoproteins. Proc. Natl Acad. Sci. USA, 102, 17372-17377.
26. Ye,Y. et al. (2008) Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev. Res., 14, 460-469.
27. Spitz,M.R. et al. (2005) Integrative epidemiology: from risk assessment to outcome prediction. J. Clin. Oncol., 23, 267-275.
28. Wan,D. et al. (2004) Two variants of the human hepatocellular carcinoma-associated HCAP1 gene and their effect on the growth of the human liver cancer cell line Hep3B. Genes Chromosomes Cancer, 9, 48-58.
29. MacRae,I.J. et al. (2007) Structural determinants of RNA recognition and cleavage by Dicer. Nat. Struct. Mol. Biol., 14, 934-940.
30. Merritt,W.M. et al. (2008) Dicer, Drosha, and outcomes in patients with ovarian cancer. N. Engl. J. Med., 359, 2641-2650.
31. Zhang,L. et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl Acad. Sci. USA, 103, 9136-9141.
32. Chiosea,S. et al. (2007) Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res., 67, 2345-2350.
33. Karube,Y. et al. (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci., 96, 111-115.
34. Sugito,N. et al. (2006) RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin. Cancer Res., 12, 7322-7328.
35. Chiosea,S. et al. (2006) Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am. J. Pathol., 169, 1812-1820.
36. Landi,D. et al. (2008) A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. DNA Cell Biol., 27, 35-43.
37. Williams,A.E. et al. (2008) Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem. Soc. Trans., 36, 1211-1215.
38. Lin,S.L. et al. (2008) Loss of mir-146a function in hormone-refractory prostate cancer. RNA, 14, 417-424.
39. Hurst,D.R. et al. (2009) Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res., 69, 1279-1283.
40. Shen,J. et al. (2008) A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis, 29, 1963-1966.
41. Xu,T. et al. (2008) A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis, 29, 2126-2131.
42. Schimanski,C.C. et al. (2009) High miR-196a levels promote the onco-genic phenotype of colorectal cancer cells. World J. Gastroenterol., 15, 2089-2096.
43. Maru,D.M. et al. (2009) MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am. J. Pathol., 174, 940-948.
44. Luthra,R. et al. (2008) MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene, 27, 6667-6678.
45. Hu,Z. et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest., 118, 2600-2608.
46. Boren,T. et al. (2008) MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol. Oncol., 110, 206-215.
47. Kawanami,D. et al. (2009) Kruppel-like factor 2 inhibits hypoxia-inducible-factor-1 alpha expression and function in the endothelium. J. Biol. Chem., 284, 20522-20530.